Insight

OTC vs Public Raises: Why Strategic OTC Allocation Is Winning in 2026

In 2026, projects increasingly optimize for control and market formation—not visibility. OTC structures offer intentionality that public raises rarely do.

It's been a year of us venturing into the venture market, and one thing we have realized is that the conversation around fundraising in Web3 has become less about visibility and more about control. Projects are beginning to realize that how capital enters the ecosystem matters just as much as how much of it is raised. Within this shift, OTC raises have quietly emerged as the more strategic path. Amidst several other paths, OTC offers something the public markets rarely do, and that’s “intentionality”.

At its core, an OTC raise allows a project to choose its early believers. This is not a small advantage. In public raises, participation is open, often driven by short-term excitement and opportunistic behavior. In contrast, OTC deals are negotiated, structured, and selective. Founders have the ability to align with participants who understand the long-term vision, who are willing to commit under defined terms, and who are less likely to react impulsively when market conditions change. This level of control creates a foundation that is far more stable than what public participation typically offers.

There is also a deeper strategic layer to OTC that many overlook. The early stage of any token is its most fragile phase. Price discovery is highly sensitive, liquidity is still forming, and perception can shift rapidly. By prioritizing OTC allocations, teams can reduce the chaos that often comes with open market speculation. Instead of exposing the token to unpredictable demand and immediate volatility, they are able to introduce supply in a measured way, ensuring that the market develops with some degree of structure.

Another important advantage lies in relationship building. OTC participants are not just buyers; they are often partners. These are funds, market participants, and ecosystem players who bring more than capital to the table. They provide strategic guidance, access to liquidity channels, and in many cases, long-term support that extends beyond the initial raise. This transforms fundraising from a transactional event into a collaborative process, where both sides are invested in the success of the project over time.

Public raises, while valuable for visibility, often come with a hidden cost. The openness that makes them attractive also introduces inconsistency. Participants enter at scale, but without uniform expectations. Some are there for the long term, while many are positioned for immediate exits. This creates a fragmented holder base that can become difficult to manage, especially when the token begins trading. The result is often early volatility that is not tied to fundamentals, but to behavior.

OTC, writing as a venture who has experienced being involved in ones that were structured properly, mitigates much of this risk. Through vesting schedules, negotiated terms, and clear communication, projects can shape the behavior of their early token holders. This does not eliminate sell pressure entirely, but it makes it more predictable and easier to manage. In a market where perception is everything, predictability becomes a powerful advantage.

What distinguishes the most successful projects today is their ability to think beyond the raise itself. They understand that fundraising is not just about capital inflow, but about market formation. By leaning into OTC, they are effectively designing the early conditions under which their token will exist. They are choosing stability over noise, alignment over access, and long-term positioning over short-term attention.

This is not to suggest that public participation has no role to play. It still serves as a powerful tool for community building and narrative expansion. However, in the current landscape, it works best as a complement, not the foundation. The core strength of a project’s capital structure is increasingly being built behind closed doors, where strategy can be executed without the distortion of hype.

The rising preference for OTC in 2026 is strongly reflecting this broader evolution in Web3 thinking. We have seen the industry moving away from exposure-driven decisions and toward structure-driven ones. Soon, we will experience an alarming number of projects that would no longer be concerned about how loud they can be on CT, but how well they can build.

Bethany Ventures does not provide financial advice.